(5S,8AS,9S)-9-HYDROXY-5-METHYL-4,6,7,8,8A,9-HEXAHYDROTHIENO-[3,2-F]-INDOLIZIN-5-IUM-IODIDE
Compound with spectra: 1 NMR
![(5S,8AS,9S)-9-HYDROXY-5-METHYL-4,6,7,8,8A,9-HEXAHYDROTHIENO-[3,2-F]-INDOLIZIN-5-IUM-IODIDE](/api/compound/3gNmndtzAgG.png?ph=true&h=300&w=458 "(5S,8AS,9S)-9-HYDROXY-5-METHYL-4,6,7,8,8A,9-HEXAHYDROTHIENO-[3,2-F]-INDOLIZIN-5-IUM-IODIDE")
| SpectraBase Compound ID | 3gNmndtzAgG |
|---|---|
| InChI | InChI=1S/C11H16NOS.HI/c1-12-5-2-3-9(12)10(13)11-8(7-12)4-6-14-11;/h4,6,9-10,13H,2-3,5,7H2,1H3;1H/q+1;/p-1/t9-,10-,12?;/m0./s1 |
| InChIKey | LSGGDFJIUXEKFF-WERZMDRISA-M |
| Mol Weight | 337.22 g/mol |
| Molecular Formula | C11H16INOS |
| Exact Mass | 336.99973 g/mol |
| Parent InChIKey | BZUOORCTTSVKIY-HVFQMFNGSA-M |
| Enantiomer InChIKey | LSGGDFJIUXEKFF-ROWYMRIBSA-M |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
(8AS,9S)-(+)-9-HYDROXY-4,6,7,8,8A,9-HEXAHYDROTHIENO-[3,2-F]-INDOLIZIN-6-ONE
(+-)-(5R,1'S)-N-allyl-5-[1-hydroxy-1-(2-thyenyl)allyl]-pyrrolidin-2-one
4-methyl-5-[(2-thienyl)sulfonyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
Clopidogrel-M (CO2)
3H-[1]Benzothieno[3,2-d]azonine-3-carbonitrile, 1,2,4,5,6,7-hexahydro-7-oxo-
(5E,7E)-9,10-Secocholesta-5,7-diene-3,25-diol
(4-S)-BENZYL-3-[(2-R,3-S)-3-HYDROXY-3-(4-METHOXYPHENYL)-2-(TRIFLUOROMETHYL)-PROPANOYL]-OXAZOLIDIN-2-ONE
(4-S)-BENZYL-3-[(2-S,3-S)-3-HYDROXY-3-(4-METHOXYPHENYL)-2-(TRIFLUOROMETHYL)-PROPANOYL]-OXAZOLIDIN-2-ONE
(10R,10aS)-10-Hydroxy-1,2,3,5,10,10a-hexahydrobenzo[f]indolizine-3-one
No Name
| Title | Journal or Book | Year |
|---|---|---|
| Combined Chemical, Biological and Theoretical DFT-QTAIM Study of Potent Glycosidase Inhibitors Based on Quaternary Indolizinium Salts | European Journal of Organic Chemistry | 2012 |